Undetectable thyroglobulin makes
123I whole-body scan
Differentiated thyroid Cancer
Thyroglobulin
Ultrasound of the neck
Journal
Thyroid research
ISSN: 1756-6614
Titre abrégé: Thyroid Res
Pays: England
ID NLM: 101469037
Informations de publication
Date de publication:
19 Oct 2021
19 Oct 2021
Historique:
received:
31
05
2021
accepted:
30
09
2021
entrez:
20
10
2021
pubmed:
21
10
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Differentiated thyroid cancer (DTC) is a common malignancy with increasing incidence. Follow-up care for DTC includes thyroglobulin (Tg) measurement and ultrasound (US) of the neck, combined with This was a retrospective, observational study. Patients with pathologically confirmed DTC, treated with total thyroidectomy and Forty patients were eligible for analysis. A total of 24 out of the 40 patients (60%) had an undetectable high-sensitive Tg 6 months after total thyroidectomy. None of these patients had a stimulated Tg above 1 ng/mL, or remnant on the This study shows that an undetectable high-sensitive Tg can change the management of patients with DTC and decrease the use and need of stimulated Tg and
Sections du résumé
BACKGROUND
BACKGROUND
Differentiated thyroid cancer (DTC) is a common malignancy with increasing incidence. Follow-up care for DTC includes thyroglobulin (Tg) measurement and ultrasound (US) of the neck, combined with
METHODS
METHODS
This was a retrospective, observational study. Patients with pathologically confirmed DTC, treated with total thyroidectomy and
RESULTS
RESULTS
Forty patients were eligible for analysis. A total of 24 out of the 40 patients (60%) had an undetectable high-sensitive Tg 6 months after total thyroidectomy. None of these patients had a stimulated Tg above 1 ng/mL, or remnant on the
CONCLUSIONS
CONCLUSIONS
This study shows that an undetectable high-sensitive Tg can change the management of patients with DTC and decrease the use and need of stimulated Tg and
Identifiants
pubmed: 34666793
doi: 10.1186/s13044-021-00114-0
pii: 10.1186/s13044-021-00114-0
pmc: PMC8524885
doi:
Types de publication
Journal Article
Langues
eng
Pagination
23Informations de copyright
© 2021. The Author(s).
Références
Int J Cancer. 2015 May 1;136(9):2187-95
pubmed: 25284703
J Clin Endocrinol Metab. 2015 Aug;100(8):E1074-83
pubmed: 26079778
Clin Endocrinol (Oxf). 2004 Jul;61(1):61-74
pubmed: 15212646
Minerva Endocrinol. 2006 Jun;31(2):173-8
pubmed: 16682940
Eur J Nucl Med Mol Imaging. 2017 May;44(5):741-743
pubmed: 28154904
World J Nucl Med. 2018 Jan-Mar;17(1):41-45
pubmed: 29398964
J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53
pubmed: 22679061
J Endocrinol Invest. 2011 Sep;34(8):e219-23
pubmed: 21399390
J Clin Endocrinol Metab. 2007 Jan;92(1):82-7
pubmed: 17077133
J Clin Endocrinol Metab. 2014 Feb;99(2):440-7
pubmed: 24285679
Eur J Endocrinol. 2017 May;176(5):497-504
pubmed: 28137736
Eur J Endocrinol. 2014 Aug;171(2):R33-46
pubmed: 24743400
Eur J Endocrinol. 2018 Jan;178(1):75-82
pubmed: 29142052
J Clin Endocrinol Metab. 2010 Dec;95(12):5241-8
pubmed: 20843945
Thyroid. 2018 Jun;28(6):722-728
pubmed: 29665748
Clin Endocrinol (Oxf). 2012 May;76(5):734-40
pubmed: 22050475
Thyroid. 2019 Jan;29(1):71-78
pubmed: 30351209
J Clin Endocrinol Metab. 2017 Mar 1;102(3):893-902
pubmed: 27929713
Clin Nucl Med. 2012 Mar;37(3):229-34
pubmed: 22310247
Scand J Clin Lab Invest Suppl. 2016;245:S119-23
pubmed: 27542000
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Lancet. 2016 Dec 3;388(10061):2783-2795
pubmed: 27240885